HDAC2 and breast cancer: 18 groups of combined genes, consisted of seven altered and prognostic genes (BRCA1, HDAC2, MCL1, PIK3R1, PSMD4, RB1, and TP53), describe the biological alterations that differentiate the 73 basal BC patients of TCGA dataset (Table 1).